Skip to main content
. Author manuscript; available in PMC: 2016 Apr 13.
Published in final edited form as: Cancer Prev Res (Phila). 2014 Oct 27;7(12):1173–1178. doi: 10.1158/1940-6207.CAPR-14-0364

Figure 2.

Figure 2

IPNs and probability of cancer. Schematic representation of current prediction models compared with how improved prediction models could benefit clinical management. Probabilities of IPNs to represent lung cancer are based on their clinical presentation with recommended follow-up. Low probability is considered 0% to 5%, intermediate 6% to 60%, and high 61% to 100% (based on Wahidi et al; ref. 16) Improved predictive models could dramatically reclassify nodules into different probability groups to address the likelihood of cancer at initial discovery.